CN1650951A - Lycophyll mixture - Google Patents
Lycophyll mixture Download PDFInfo
- Publication number
- CN1650951A CN1650951A CNA2004100772041A CN200410077204A CN1650951A CN 1650951 A CN1650951 A CN 1650951A CN A2004100772041 A CNA2004100772041 A CN A2004100772041A CN 200410077204 A CN200410077204 A CN 200410077204A CN 1650951 A CN1650951 A CN 1650951A
- Authority
- CN
- China
- Prior art keywords
- milligrams
- lycopene
- oil
- natural
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims description 15
- JEVVKJMRZMXFBT-CCHFXWJWSA-N lycophyll Chemical compound OCC(/C)=C/CC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CC\C=C(/C)CO JEVVKJMRZMXFBT-CCHFXWJWSA-N 0.000 title 1
- 235000018626 lycophyll Nutrition 0.000 title 1
- 235000012661 lycopene Nutrition 0.000 claims abstract description 33
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 32
- 239000001751 lycopene Substances 0.000 claims abstract description 31
- 229960004999 lycopene Drugs 0.000 claims abstract description 31
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 31
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 30
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 13
- 235000012424 soybean oil Nutrition 0.000 claims abstract description 11
- 235000019198 oils Nutrition 0.000 claims abstract description 8
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 6
- 235000002677 phytofluene Nutrition 0.000 claims abstract description 6
- OVSVTCFNLSGAMM-KGBODLQUSA-N cis-phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/C=C/C=C(C)/CCC=C(/C)CCC=C(C)C)C)C)C)C OVSVTCFNLSGAMM-KGBODLQUSA-N 0.000 claims abstract description 4
- OVSVTCFNLSGAMM-UZFNGAIXSA-N phytofluene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=C\C=C(/C)\C=C\C=C(C)CCC=C(C)CCC=C(C)C OVSVTCFNLSGAMM-UZFNGAIXSA-N 0.000 claims abstract description 4
- ZYSFBWMZMDHGOJ-SGKBLAECSA-N phytofluene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)C=CC=C(/C)CCC=C(C)C)C)C)C)C ZYSFBWMZMDHGOJ-SGKBLAECSA-N 0.000 claims abstract description 4
- ZIUDAKDLOLDEGU-UHFFFAOYSA-N trans-Phytofluen Natural products CC(C)=CCCC(C)CCCC(C)CC=CC(C)=CC=CC=C(C)C=CCC(C)CCCC(C)CCC=C(C)C ZIUDAKDLOLDEGU-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229940068065 phytosterols Drugs 0.000 claims abstract description 3
- 241000227653 Lycopersicon Species 0.000 claims abstract 8
- 240000003768 Solanum lycopersicum Species 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 7
- 239000003549 soybean oil Substances 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 150000002664 lycopenes Chemical class 0.000 claims description 3
- 235000011765 phytoene Nutrition 0.000 claims description 3
- 239000008171 pumpkin seed oil Substances 0.000 claims description 3
- 235000000832 Ayote Nutrition 0.000 claims description 2
- PMTBZAVERRPRHU-YGVNLFKFSA-N CC1(C)CCCC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C.CC1(C)CCCC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C Chemical compound CC1(C)CCCC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C.CC1(C)CCCC(C)=C1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C PMTBZAVERRPRHU-YGVNLFKFSA-N 0.000 claims description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 2
- 240000001980 Cucurbita pepo Species 0.000 claims description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 2
- 150000003032 phytoenes Chemical class 0.000 claims description 2
- 150000003033 phytofluenes Chemical class 0.000 claims description 2
- 235000015136 pumpkin Nutrition 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 235000019149 tocopherols Nutrition 0.000 claims description 2
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims 1
- 235000013402 health food Nutrition 0.000 claims 1
- 230000000007 visual effect Effects 0.000 claims 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract description 6
- 235000013734 beta-carotene Nutrition 0.000 abstract description 6
- 239000011648 beta-carotene Substances 0.000 abstract description 6
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract description 6
- 229960002747 betacarotene Drugs 0.000 abstract description 6
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract description 6
- 208000010125 myocardial infarction Diseases 0.000 abstract description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- -1 phytopene Chemical compound 0.000 abstract 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 4
- 108010007622 LDL Lipoproteins Proteins 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000009329 organic farming Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A lycopene mixtuer for preventing arteriosclerosis, myocardial infarction and chronic heart disease is proportionally prepared from natural tomato extract and soya oil. Said natural tomato extract is composed of lycopene, phytopene, phytofluene, beta-carotene, VE, phytosterols, phospholipids, and tomato oil.
Description
[affiliated technical field]
The present invention is relevant a kind of lycopene mixture, refers in particular to a kind of organic farming, and natural extraction is pollution-free, to the harmless side effect of human body, can effectively provide the lycopene mixture of human nutrition, belongs to field of health care food.
[background technology]
Lycopene (Lycopene) is to be present in the blood plasma and hetero-organization thereof of human body, and in the shared various types of carotene ratio of human plasma, lycopene also occupies maximum ratio, it is 2.5 times of beta-carotene, 7.5 times of alpha-carotene, this has proved the importance of lycopene in human body ego defense system.
Chinese scholars studies confirm that, the antioxidant effect of lycopene is more than beta-carotene, vitamin E is much higher, can effectively eliminate various deleterious oxygen radicals, and is particularly leading especially for the elimination ability of simple gland attitude oxygen (Single Oxygen).Therefore, lycopene can be promoted the resistance of human body for low density lipoprotein, LDL LDL Oxidation widely, and then can harden by prevention of arterial, for myocardial infarction and morbus cardiacus ... or the like the prevention of cardiovascular disease do a great deal of good.
Furthermore, lycopene or beta-carotene all have been found and can have protected human lymphoid's ball antagonism NO
2This damage of radicals, and NO
2Free radical is a topmost toxic ingredient in air pollution and the smoking, and lycopene antagonism NO
2Effect be the twice of beta-carotene at least.Therefore, replenish lycopene and absolute benefiting arranged for present serious air pollution or second hand smoking problem.
Because lycopene derives from the Fructus Lycopersici esculenti cell wall, and in the tissue of protein and fiber, so be difficult for being absorbed by human body.Therefore, even the process of direct edible fresh Fructus Lycopersici esculenti also is difficult for from wherein absorbing the effective lycopene dosage of human body.
Therefore, must effectively extract the lycopene in the Fructus Lycopersici esculenti, make it can be effective absorption of human body 100%, can reach the significant health efficacy of expection at short notice human body.
[summary of the invention]
The present invention's main purpose provides a kind of lycopene mixture, it is to adopt lycopene, phytoene, phytofluene, beta-carotene, natural Vitamin E, phytosterol, phospholipid, natural tomato extract that tomato oil formed, cooperate soybean oil or the made mixture of pumpkin seed oil, can effectively be absorbed by human body, and the good efficacy of performance lycopene.
For reaching the lycopene mixture of stating goal of the invention, be the tomato variety that adopts natural organic farming, remove tomato fibre and cell wall in the Fructus Lycopersici esculenti, and then the active lycopene raw material that directly extracts.And in extractive process, not involving any chemical step, the mode that does not change former material fully extracts, and avoids the pollution of other materials, is the pollution-free product of complete natural health.This lycopene raw material is finished goods via aforementioned prescription, not only is absorption of human body easily, brings into play health efficacy, and pollution-free, can not cause the burden of human body.
The present invention's lycopene mixture is organic farming, natural extraction, can be absorption of human body effectively easily, antioxidant effect is good, can promote the resistance of human body greatly for low density lipoprotein, LDL LDL Oxidation, so can prevention of arterial sclerosis, do a great deal of good for the prevention of cardiovascular disease such as myocardial infarction and morbus cardiacus, to the harmless side effect of human body, can be made into various forms of health-care foods.
[graphic explanation]
To elaborate to closing graphic and a preferred embodiment of the present invention below, can further understand the present invention's technology contents and purpose effect thereof.
Figure one is the present invention's composition ratio chart
[specific embodiment]
Press shown in the accompanying drawing one, the present invention provides a kind of lycopene mixture, it includes natural tomato extract (Naturaltomato extract) 250.00 milligrams (mg) and 100.00 milligrams of soybean oils (Soya Oil), this composition weight is to test the dosage of suitable absorption of human body, but difference and demand according to user, also can adjust its weight in proportion, amplitude peak can reach ± and 50%.
Further segmenting in the aforementioned natural tomato extract has:
15.00 milligrams of lycopenes (Lycopene);
1.50 milligrams of phytoenes (Phytopene);
1.25 milligrams of phytofluenes (Phytofluene);
Beta-carotene (β-carotene) 0.50 milligram;
5.00 milligrams of natural Vitamin E (Tocopherols (VitaminE));
1.50 milligrams of phytosterol (Phytosterols);
25.00 milligrams of phospholipid (Phospholipids); And
200.00 milligrams of tomato oils (Tomato Oil).
Still 0.25 milligram of less than in the aforementioned component provides that the non-material that mainly is difficult to again avoid uses when producing.
Again, this soybean oil (Soya Oil) is replaceable to be pumpkin seed oil (Pumpkin Oil), or is replaced by the material of other equivalent nutrients, with the performance identical function.
Claims (4)
1, a kind of lycopene mixture includes natural tomato extract (Natural tomato extract) 250.00 milligrams (mg) and 100.00 milligrams of soybean oils (Soya Oil), includes in this natural tomato extract:
15.00 milligrams of lycopenes (Lycopene);
1.50 milligrams of phytoenes (Phytopene);
1.25 milligrams of phytofluenes (Phytofluene);
Beta-carotene (β-carotene) 0.50 milligram;
5.00 milligrams of natural Vitamin E (Tocopherols (VitaminE));
1.50 milligrams of phytosterol (Phytosterols);
25.00 milligrams of phospholipid (Phospholipids); And
200.00 milligrams of tomato oils (Tomato Oil).
2, the lycopene mixture according to claim 1, wherein this natural tomato extract and the visual user picked-up of soybean oil demand are adjusted it ± 50% weight.
3, according to claim 1 or 2 described lycopene mixture, wherein this soybean oil (Soya Oil) is replaceable is pumpkin seed oil (Pumpkin Oil).
4, according to claim 1,2 or 3 described lycopene mixture, it is characterized in that can be made into capsule or other various forms of health foods.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100772041A CN100488535C (en) | 2004-12-09 | 2004-12-09 | Lycopin mixture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100772041A CN100488535C (en) | 2004-12-09 | 2004-12-09 | Lycopin mixture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1650951A true CN1650951A (en) | 2005-08-10 |
| CN100488535C CN100488535C (en) | 2009-05-20 |
Family
ID=34869059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100772041A Active CN100488535C (en) | 2004-12-09 | 2004-12-09 | Lycopin mixture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100488535C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015181362A (en) * | 2014-03-20 | 2015-10-22 | 一般財団法人バイオダイナミックス研究所 | High-functional edible oil and manufacturing method thereof |
| CN105682684A (en) * | 2013-12-11 | 2016-06-15 | 健永生技股份有限公司 | Vehicular open/close member control device and control method |
| CN108669557A (en) * | 2018-05-20 | 2018-10-19 | 苏州工业园区联创生物科技有限公司 | Soft capsule dosage form and preparation method thereof containing natural tomato extract liquor pumpkin seed oil |
| US10813968B2 (en) | 2012-12-24 | 2020-10-27 | Provexis Natural Products Limited | Method of treating a human suffering from post exercise muscle soreness |
| US10864241B2 (en) | 2012-04-23 | 2020-12-15 | Provexis Natural Products Limited | Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract |
| US10905733B2 (en) | 2016-11-02 | 2021-02-02 | Provexis Natural Products Limited | Water soluble tomato extract protects against adverse effects of air pollution |
| US10973865B2 (en) | 2008-10-31 | 2021-04-13 | Provexis Natural Products Limited | Method of making solanaceae fruit extracts |
-
2004
- 2004-12-09 CN CNB2004100772041A patent/CN100488535C/en active Active
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10973865B2 (en) | 2008-10-31 | 2021-04-13 | Provexis Natural Products Limited | Method of making solanaceae fruit extracts |
| US10864241B2 (en) | 2012-04-23 | 2020-12-15 | Provexis Natural Products Limited | Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract |
| US10813968B2 (en) | 2012-12-24 | 2020-10-27 | Provexis Natural Products Limited | Method of treating a human suffering from post exercise muscle soreness |
| CN105682684A (en) * | 2013-12-11 | 2016-06-15 | 健永生技股份有限公司 | Vehicular open/close member control device and control method |
| CN107260675A (en) * | 2013-12-11 | 2017-10-20 | 健永生技股份有限公司 | The medical composition of carotenoid |
| CN107260675B (en) * | 2013-12-11 | 2018-12-18 | 健永生技股份有限公司 | The medical composition of carotenoid |
| CN110200917A (en) * | 2013-12-11 | 2019-09-06 | 健永生技股份有限公司 | The medical composition of carotenoid |
| CN110200917B (en) * | 2013-12-11 | 2021-09-21 | 健永生技股份有限公司 | Pharmaceutical compositions of carotenoids |
| JP2015181362A (en) * | 2014-03-20 | 2015-10-22 | 一般財団法人バイオダイナミックス研究所 | High-functional edible oil and manufacturing method thereof |
| US10905733B2 (en) | 2016-11-02 | 2021-02-02 | Provexis Natural Products Limited | Water soluble tomato extract protects against adverse effects of air pollution |
| CN108669557A (en) * | 2018-05-20 | 2018-10-19 | 苏州工业园区联创生物科技有限公司 | Soft capsule dosage form and preparation method thereof containing natural tomato extract liquor pumpkin seed oil |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100488535C (en) | 2009-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9192671B2 (en) | Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans | |
| EP1876906B1 (en) | Nutritional supplement or functional food comprising oil combination | |
| ES2351141B1 (en) | FUNCTIONAL OILS BASED ON OLIVE OIL. | |
| WO2011057183A1 (en) | Nutritional supplements for relief of dry eye | |
| US10857108B2 (en) | Composition for preventing and/or treating cardiovascular and cerebrovascular diseases | |
| Güven et al. | Physiochemical composition of fig seed oil from Turkey | |
| GHASEMINASAB et al. | A review on pistachio: Its composition and benefits regarding the prevention or treatment of diseases | |
| CN1650951A (en) | Lycophyll mixture | |
| DE202018105987U1 (en) | A composition for relieving joint pain using hyaluronic acid and egg shell membrane components | |
| DE212015000033U1 (en) | Therapeutic astaxanthin and phospholipid composition | |
| Subermaniam et al. | Virgin Coconut Oil (VCO) decreases the level of malondialdehyde (MDA) in the cardiac tissue of experimental Sprague-Dawley rats fed with heated palm oil | |
| DE202018105422U1 (en) | A composition for relieving joint pain using hyaluronic acid and egg shell membrane components | |
| CN105395925A (en) | Composition with hypotensive and anti-obesity effects based on blood fat reduction | |
| RU2396073C2 (en) | Oral composition for skin improvement | |
| EP0273407B1 (en) | Medicine for improving the specific properties of blood | |
| GB2217173A (en) | Nutritional and medicinal compositions | |
| DE69530605T2 (en) | LYCOPEN-CONTAINING PHARMACEUTICAL COMPOSITIONS | |
| CN1298647A (en) | Health-care oil for regulating blood fat | |
| AU2015354848C1 (en) | Formulation for effective tocotrienol delivery | |
| WO2008011179A2 (en) | Omega-3 fatty acids for use in treating resistant hypertension | |
| CN1141934C (en) | Health-care oil for regulating blood fat | |
| Papandreou et al. | An updated mini review on grapefruit: Interactions with drugs, obesity and cardiovascular Risk factors | |
| CN1255167C (en) | Anti-oxidation health care nutrient oil | |
| CN109123674A (en) | A kind of black fruit fructus lycii compound alleviation visual fatigue piece and its preparation process | |
| RU2019123087A (en) | COMPOSITION OF OMEGA-3 FATTY ACIDS FOR PREVENTION AND / OR TREATMENT OF CACHEXIA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: GUO FUFENG Free format text: FORMER OWNER: NINGBO JIANYONG BIOLOGY SCIENCE CO., LTD. Effective date: 20071228 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20071228 Address after: Shanghai City, Pudong New Area Waigaoqiao Taigu Road No. 18 room 605 post encoding: 200131 Applicant after: Guo Fufeng Address before: 3B1 post encoding No. 7 Zhejiang Avenue business city of Ningbo province Ningbo Free Trade Zone: 315800 Applicant before: NINGBO JIANYONG BIOLOGICAL SCIENCE AND TECHNOLOGYCO., Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HEALTH EVER BIO-TECH CO., LTD. Free format text: FORMER OWNER: GUO FUFENG Effective date: 20130201 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200131 PUDONG NEW AREA, SHANGHAI TO: TAIWAN, CHINA |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130201 Address after: Taiwan, Taipei, China Wenshan Nanjing East Road, paragraph 186, No. 11, building 4, 9 Patentee after: HEALTH-EVER BIOTECH CO.,LTD. Address before: 200131 Shanghai City, Pudong New Area Waigaoqiao Taigu Road No. 18 room 605 Patentee before: Guo Fufeng |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210513 Address after: Room 1203-4, 12 / F, Hong Kong Trade Centre, 161-167 des Voeux Road Central, Hong Kong, China Patentee after: Dingshunxing Co.,Ltd. Address before: Taiwan, Taipei, China Wenshan Nanjing East Road, paragraph 186, No. 11, building 4, 9 Patentee before: Health-Ever Biotech Co.,Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20221130 Address after: Singapore, Singapore City Patentee after: Jianyong Biotechnology International Pte. Ltd. Address before: Room 1203-4, 12 / F, Hong Kong Trade Centre, 161-167 des Voeux Road Central, Hong Kong, China Patentee before: Dingshunxing Co.,Ltd. |
|
| TR01 | Transfer of patent right |